The goal of this study is to investigate the synergistic effects of OL, a small-molecule PARP inhibitor, and GA, a plant-derived active compound, on cell proliferation and apoptosis in OL-resistant human osteosarcoma U2OS cells (U2OS-PIR). The gene discussed is PARP1; the disease is osteosarcoma.